Company
Vesteck
Cutting-Edge Solution for endograft fixation.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Vesteck is dedicated to revolutionizing the healthcare industry with our advanced solution for EVAR/TEVAR endograft fixation. Through the development of an advanced endosuturing platform (ESAR).
Funding snapshot
- Total raised
- $7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Grant, $2M2025-09-23
Funding rounds
- Round, 2025
- $354K2025-10-16, SEC form D sold, 15 investors
- Grant
- $2M2025-09-23, Company stated
- Round, 2022
- $2.3M2022-12-19, SEC form D sold, 30 investors
- Round, 2021
- $4.4M2021-08-23, SEC form D sold, 38 investors
Products
- Hardware
- Suture-Tight™
Loading relationship preview